Hermann Eichler

Physician
Institute of Clinical Hemostaseology and Transfusion Medicine, Saarland University and University Hospital, Homburg, Germany
Homburg/Saar, Saarland, Germany

Presentation(s):

• PB0262 - Effectiveness of emicizumab under real-world conditions in patients of all ages with hemophilia A with and without FVIII inhibitors: Third interim analysis of the non-interventional study EMIIL

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• OC 40.4 - Concizumab efficacy results at 56-week cut-off in patients with hemophilia A/B without inhibitors: an intra-patient analysis from the phase 3 explorer8 study

  Monday, June 24, 2024
  15:30 – 15:45 ICT